Inside Abbott’s tactics to save AIDS drug
By John Carreyrou
The Wall Street Journal Europe
04 Jan 2007
Inthefallof2003, AbbottLaboratoriesgrewworriedaboutnewcompetition to its flagship AIDS drug, Kaletra. Thenit seizedonanunusual weapon that helped Kaletra’s global sales top $1 billion a year, even as it exposed Abbott to criticism that it was... read more...
posted by Bank Report at
12:39 PM
0 Comments:
Post a Comment
<< Home